Dashboard
Manage Tickers

WPCW. P. Carey Inc.

NYSE wpcarey.com


$ 55.71 $ 0.67 (1.22 %)    

Monday, 29-Apr-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 55.7
$ 55.71
$ 0.00 x 0
$ 0.00 x 0
$ 55.42 - $ 56.13
$ 49.13 - $ 68.92
1,151,015
na
12.02B
$ 1.15
$ 16.97
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-09-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 07-28-2023 06-30-2023 10-Q
4 04-28-2023 03-31-2023 10-Q
5 02-10-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 07-29-2022 06-30-2022 10-Q
8 04-29-2022 03-31-2022 10-Q
9 02-11-2022 12-31-2021 10-K
10 10-29-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 04-30-2021 03-31-2021 10-Q
13 02-12-2021 12-31-2020 10-K
14 10-30-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-01-2020 03-31-2020 10-Q
17 02-21-2020 12-31-2019 10-K
18 11-01-2019 09-30-2019 10-Q
19 08-02-2019 06-30-2019 10-Q
20 05-03-2019 03-31-2019 10-Q
21 02-25-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-03-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-23-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-24-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-18-2015 03-31-2015 10-Q
37 03-02-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-initiates-coverage-on-wp-carey-with-equal-weight-rating-announces-price-target-of-55
Barclays Initiates Coverage On W.P. Carey ...
03/27/2024 10:58:23

Barclays initiates coverage on W.P. Carey (NYSE:WPC) with a Equal-Weight rating and announces Price Target of $55.

w-p-carey-increases-quarterly-dividend-from-086-to-0865-per-share
W. P. Carey Increases Quarterly Dividend F...
03/14/2024 20:35:04

The dividend is payable on April 15, 2024 to stockholders of record as of March 28, 2024. The dividend is equivalent to an annu...

scotiabank-maintains-sector-perform-on-wp-carey-lowers-price-target-to-60
Scotiabank Maintains Sector Perform on W.P...
03/04/2024 16:26:13

Scotiabank analyst Nicholas Yulico maintains W.P. Carey (NYSE:WPC) with a Sector Perform and lowers the price target from $6...

wpc---analyzing-wp-careys-short-interest
(WPC) - Analyzing W.P. Carey's Short Interest
03/04/2024 15:00:16

4-reits-hit-by-analyst-downgrades-this-week
4 REITs Hit By Analyst Downgrades This Week
02/22/2024 22:30:20

expert-ratings-for-wp-carey
Expert Ratings For W.P. Carey
02/20/2024 18:00:39

top-4-real-estate-stocks-youll-regret-missing-this-quarter
Top 4 Real Estate Stocks You'll Regret Mis...
02/15/2024 12:10:52

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

rbc-capital-maintains-outperform-on-wp-carey-lowers-price-target-to-65
RBC Capital Maintains Outperform on W.P. C...
02/12/2024 16:11:33

RBC Capital analyst Brad Heffern maintains W.P. Carey (NYSE:WPC) with a Outperform and lowers the price target from $68 to $65.

raymond-james-downgrades-wp-carey-to-market-perform
Raymond James Downgrades W.P. Carey to Mar...
02/12/2024 12:07:25

Raymond James analyst RJ Milligan downgrades W.P. Carey (NYSE:WPC) from Outperform to Market Perform.

why-commercial-real-estate-company-wp-carey-shares-are-down-today
Why Commercial Real Estate Company W.P. Ca...
02/09/2024 17:37:20

W.P. Carey faces market reaction as Q4 FY23 earnings reveal a revenue increase to $412.4 million but a decline in AFFO per shar...

w-p-carey-expects-to-report-2024-affo-per-share-of-465-475-est-470
W. P. Carey Expects To Report 2024 AFFO Pe...
02/09/2024 12:33:57

wp-carey-q4-affo-per-share-119-misses-121-estimate-sales-41038m-miss-42212m-estimate
W.P. Carey Q4 AFFO Per Share $1.19 Misses ...
02/09/2024 12:32:04

W.P. Carey (NYSE:WPC) reported quarterly AFFO of $1.19 per share which missed the analyst consensus estimate of $1.21 by 1.65 p...

earnings-scheduled-for-february-9-2024
Earnings Scheduled For February 9, 2024
02/09/2024 09:55:45

Companies Reporting Before The Bell • TELUS (NYSE:TU) is expected to report quarterly earnings at $0.23 per share on revenue o...

rbc-capital-maintains-outperform-on-wp-carey-raises-price-target-to-68
RBC Capital Maintains Outperform on W.P. C...
01/11/2024 16:26:48

RBC Capital analyst Brad Heffern maintains W.P. Carey (NYSE:WPC) with a Outperform and raises the price target from $66 to $68.

w-p-carey-announced-the-sale-of-a-portfolio-of-70-office-properties-net-leased-to-the-state-of-andalusia-for-about-359m
W. P. Carey Announced The Sale Of A Portfo...
01/11/2024 12:40:31

raymond-james-maintains-outperform-on-wp-carey-raises-price-target-to-68
Raymond James Maintains Outperform on W.P....
01/08/2024 17:45:32

Raymond James analyst RJ Milligan maintains W.P. Carey (NYSE:WPC) with a Outperform and raises the price target from $63 to ...

earnings-scheduled-for-november-3-2023
Earnings Scheduled For November 3, 2023
11/03/2023 11:12:01

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...

preview-wp-careys-earnings
Preview: W.P. Carey's Earnings
11/02/2023 17:01:29

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

  On Tuesday, 647 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

  On Monday, 369 companies set new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION